MZB1 and neoplasm: In primary gastric cancer, low MZB1 expression is correlated with a higher risk of recurrence following curative resection, as MZB1’s suppressive role links its reduced levels to increased hematogenous recurrence and changes in tumor progression-related gene expression [16].